COVID-19 Response

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The Duke-Margolis Institute for Health Policy has marshalled its outstanding network of experts to respond to the crisis in real time, guiding Federal and state leaders through this extraordinarily difficult period....

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The...

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The...

Read More

Digital Health & AI

Through Duke-Margolis’s Artificial Intelligence (AI) and Digital Health Technologies (DHT) portfolios, we are committed to developing and supporting the implementation of practical and inclusive digital health and AI policies that increase evidence-based innovation and improve health outcomes,...

Through Duke-Margolis’s Artificial Intelligence (AI) and Digital Health Technologies (DHT)...

Through Duke-Margolis’s Artificial Intelligence (AI) and Digital Health Technologies (DHT)...

Read More

Drug Pricing and Competition Policy

Novel technologies typically come to market with high list prices that fall over time, but which may still be high enough to impact patient access. Reforms that target drug pricing and competition can address affordability for patients, payers, and health care organizations to ultimately increase...

Novel technologies typically come to market with high list prices that fall over time, but which may...

Novel technologies typically come to market with high list prices that fall over time, but which may...

Read More

Drug Supply Chain

Read More

Drug-Resistant Infections & Antimicrobial Resistance (AMR)

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According to the Centers for Disease Control and Prevention (CDC), each year drug-resistant infections are responsible for 35,000 lives lost in the Unites States. And the rise of AMR threatens the...

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According...

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According...

Read More

Early-Stage Alzheimer's Disease Treatment

Read More